Angelo D’Alessandro, PhD

Angelo D’Alessandro, PhD, is an Assistant Professor and Director of the Metabolomics Core of the School of Medicine and Colorado Cancer Center at the Department of Biochemistry and Molecular Genetics, University of Colorado Denver – Anschutz Medical Campus. Dr. D’Alessandro received his PhD at the Tuscia University (Italy) under the aegis of the Italian National Blood Center. His postdoctoral career focused on Mass Spectrometry-based Omics technologies at Bruker Daltonics (Bremen, Germany), Cancer Metabolism at the Beatson Institute for Cancer Center (Glasgow, Scotland) and Metabolomics in Transfusion Medicine at the University of Colorado Denver (Aurora, USA). He also serves as Linda Crnic Investigator for the Linda Crnic Institute of Down Syndrome. Dr. D’Alessandro is a founder and CSO of Omix Technologies Inc. and Altis Biosciences LLC. He serves as Associate Editor for the journal Blood Transfusion, Frontiers in Physiology, and Molecular Cell Proteomics. In 2019 he edited a thematic book on High-Throughput metabolomics for the Springer Nature series in Methods in Molecular Biology. Dr. D’Alessandro has been awarded the 2015 Scott Murphy lectureship by the Biomedical Excellence for Safer Transfusion (BEST) group, the Early Career grant by the National Blood Foundation (2016) and the 2017 Webb-Waring Early Career grant by the Boettcher Foundation. He is a National Blood Foundation Scholar (2018). Age 35, he has published over 225 papers in peer-reviewed scientific journals. Further details are available at www.dalessandrolab.com.